A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy
2017 ◽
Vol 23
(2)
◽
pp. 382-388
◽
Keyword(s):
Phase Ii
◽
Keyword(s):